Definitive Contract 75N93019C00057
Award Date
9/9/19
Potential Completion Date
8/17/24
Potential Value
$29M
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Alachua, FL 32615, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
12
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,044,549.00 fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The contract is for biomedical research and development work, with a period of performance ending on March 31, 2010. No set-aside designations were used. Resilience Government Services, a technology-focused biomanufacturing company, has...
This is a $6,821,012.21 Cost Plus Fixed Fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The contract is for the development of a broad spectrum monoclonal antibody-based therapeutic for botulism, a biological threat. The contract has no set-aside designation and the ultimate completion date is September...
This federal contract award, identified as W911QY2190008, was granted by the Department of the Army's Joint PEO Chemical and Biological Defense to the prime contractor Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The $62,096,250.00 contract, which has no set-aside designation, is for the development of a "COVID-19" Monoclonal Antibody (MAB) Sponsorship Prototype. The contract is an Other Transaction Agreement with a period of performance through...
This is a definitive contract awarded by the Department of the Army's Joint PEO Chemical and Biological Defense, a defense agency, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The $366,290,602.35 cost-plus-fixed-fee contract is for the Medical Countermeasures Advanced Development and Manufacturing (MCM ADM) Capability, with a period of performance through October 31, 2023. As a prime contractor, Resilience has provided a range of goods and services related...
This is a delivery order award under the Preclinical Services for Biopharmaceutical Product Development Indefinite Delivery Indefinite Quantity (IDIQ) contract, issued by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID). The $816,039.00 award to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.) is for stability testing of NTM-1632 and NTM-1633. This award does not...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $5,107,357.36 Other Transaction Agreement to Resilience Government Services, Inc., doing business as Nanotherapeutics Inc., a technology-focused biomanufacturing company. The contract, which has no set-aside designation, is for the development of a "Plasmid Platform Protype" and is part of a larger $5.7 million Indefinite Delivery Vehicle aimed at transferring capabilities to...
This federal contract award to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.) is valued at $9,080,310.52 and was issued by the Joint PEO Chemical and Biological Defense, part of the U.S. Department of the Army. The award is for drug substance process validation, drug product process validation, clinical development phase 3, and storage/stability activities to support the U.S. FDA licensure of the BONT MAB G03-52-01 drug product. The contract was awarded on March...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $92 million firm fixed price definitive contract to Resilience Government Services, Inc., doing business as Nanotherapeutics Inc., for fill and finish capacity. The contract is funded through the National Interest Action Code for Coronavirus COVID-19 and will be performed in Alachua, Florida through July 2021. As the prime, Nanotherapeutics will provide pharmaceutical manufacturing...
This is a delivery order contract award by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Battelle Memorial Institute, a nonprofit research and development organization, for immunogenicity and efficacy testing of medical countermeasures (vaccines and other biologics) against emerging infectious diseases including COVID-19 (SARS-CoV-2). The total ceiling value of the contract is $12,290,377.00. The contract is...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The $31,202.00 fixed-price level of effort contract is for process development of vaccine candidates, including for SARS-CoV-2. The award has an ultimate completion date of April 15, 2025. ABL has been awarded multiple indefinite...